GreenLight Biosciences Holdings

GRNA · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$167,055-$112,310-$53,251-$28,649
Dep. & Amort.$8,076$5,772$1,754$688
Deferred Tax$0$1,365$7-$5
Stock-Based Comp.$8,839$1,991$659$430
Change in WC$8,406$10,522$3,644$1,870
Other Non-Cash$5,003$828$588$30
Operating Cash Flow-$136,731-$91,832-$46,599-$25,636
Investing Activities
PP&E Inv.-$26,547-$15,148-$10,047-$1,896
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$37$109$0$0
Investing Cash Flow-$26,510-$15,039-$10,047-$1,896
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$106,029$206,750$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$200,851$43,531$125,848$13,316
Financing Cash Flow$200,851$43,531$125,848$13,316
Forex Effect$0$0$0$0
Net Chg. in Cash$37,610-$63,340$69,202-$14,216
Supplemental Information
Beg. Cash$31,808$95,148$25,946$40,162
End Cash$69,418$31,808$95,148$25,946
Free Cash Flow-$163,278-$106,980-$56,646-$27,532